comparemela.com
Home
Live Updates
EMA Approves Two Therapies for Rare Genetic Diseases : comparemela.com
EMA Approves Two Therapies for Rare Genetic Diseases
Treatments for amyotrophic lateral sclerosis and paroxysmal nocturnal hemoglobinuria have been given marketing authorization by the European Medicines Agency.
Related Keywords
Netherlands ,
,
European Medicines Agency ,
Committee For Medicinal Products Human Use ,
European Union ,
New England Journal ,
Medicinal Products ,
Human Use ,
Biogen Netherlands ,
Nocturnal Hemoglubinuria ,
Genomics Genomic Medicine ,
World Medicine ,
Foreign Medicine ,
International Medicine ,
Global Medicine ,
International Practice Of Medicine ,
Medical Innovations ,
Nnovations In Medicine ,
Innovation ,
Rare Diseases ,
Muscular Atrophy ,
Uscular Atrophies ,
Amyotrophic Lateral Sclerosis ,
Ls ,
Lou Gehrig Amp 039s Disease ,
Maladie De Charcot ,
Pain Management ,
Blood ,
Genetics ,
Myalgia ,
Muscle Pain ,
Genetic Disorder ,
comparemela.com © 2020. All Rights Reserved.